These included tumor stage, two DNA features (loss of chr 17q and 22q segments), and eight RNA features (immature dendritic cell, T-follicular helper cell, XBP1, IgG, and HER2 amplification signatures, as well as three unsupervised RNA signatures labeled Unknown8, Red18, and Green7). This evidence concerns the gene ERBB2 and neoplasm.